SRPT logo

Sarepta Therapeutics (SRPT) Current liabilities

annual current liabilities:

$731.68M+$78.03M(+11.94%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual total current liabilities is $731.68 million, with the most recent change of +$78.03 million (+11.94%) on December 31, 2024.
  • During the last 3 years, SRPT annual current liabilities has risen by +$278.95 million (+61.61%).
  • SRPT annual current liabilities is now at all-time high.

Performance

SRPT Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly current liabilities:

$605.59M-$126.10M(-17.23%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly total current liabilities is $605.59 million, with the most recent change of -$126.10 million (-17.23%) on March 1, 2025.
  • Over the past year, SRPT quarterly current liabilities has dropped by -$3.12 million (-0.51%).
  • SRPT quarterly current liabilities is now -17.23% below its all-time high of $731.68 million, reached on December 31, 2024.

Performance

SRPT quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

SRPT Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.9%-0.5%
3 y3 years+61.6%+33.1%
5 y5 years+176.3%+97.6%

SRPT Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+61.6%-17.2%+34.4%
5 y5-yearat high+176.3%-17.2%+97.6%
alltimeall timeat high>+9999.0%-17.2%>+9999.0%

SRPT Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$605.59M(-17.2%)
Dec 2024
$731.68M(+11.9%)
$731.68M(+4.6%)
Sep 2024
-
$699.49M(+1.6%)
Jun 2024
-
$688.49M(+13.1%)
Mar 2024
-
$608.71M(-6.9%)
Dec 2023
$653.66M(+5.5%)
$653.66M(+45.0%)
Sep 2023
-
$450.74M(-9.6%)
Jun 2023
-
$498.65M(-7.1%)
Mar 2023
-
$536.88M(-13.4%)
Dec 2022
$619.60M(+36.9%)
$619.60M(+2.8%)
Sep 2022
-
$602.92M(+10.5%)
Jun 2022
-
$545.57M(+19.9%)
Mar 2022
-
$454.96M(+0.5%)
Dec 2021
$452.73M(+8.8%)
$452.73M(+21.2%)
Sep 2021
-
$373.44M(-12.1%)
Jun 2021
-
$425.02M(+16.5%)
Mar 2021
-
$364.74M(-12.3%)
Dec 2020
$416.03M(+57.1%)
$416.03M(+9.9%)
Sep 2020
-
$378.39M(+6.6%)
Jun 2020
-
$354.90M(+15.8%)
Mar 2020
-
$306.43M(+15.7%)
Dec 2019
$264.77M(+52.4%)
$264.77M(+22.7%)
Sep 2019
-
$215.86M(+33.2%)
Jun 2019
-
$162.09M(+18.0%)
Mar 2019
-
$137.37M(-20.9%)
Dec 2018
$173.69M(+96.6%)
$173.69M(+51.8%)
Sep 2018
-
$114.39M(+9.3%)
Jun 2018
-
$104.69M(+14.8%)
Mar 2018
-
$91.20M(+3.2%)
Dec 2017
$88.33M(+17.1%)
$88.33M(+25.3%)
Sep 2017
-
$70.47M(+6.8%)
Jun 2017
-
$65.96M(-11.6%)
Mar 2017
-
$74.63M(-1.1%)
Dec 2016
$75.42M(+21.1%)
$75.42M(+16.2%)
Sep 2016
-
$64.93M(-3.0%)
Jun 2016
-
$66.93M(+21.3%)
Mar 2016
-
$55.16M(-11.5%)
Dec 2015
$62.29M(+69.0%)
$62.29M(+65.4%)
Sep 2015
-
$37.67M(-3.3%)
Jun 2015
-
$38.96M(+14.9%)
Mar 2015
-
$33.91M(-8.0%)
Dec 2014
$36.87M(+2.5%)
$36.87M(+62.2%)
Sep 2014
-
$22.73M(-22.7%)
Jun 2014
-
$29.40M(-22.1%)
Mar 2014
-
$37.76M(+5.0%)
Dec 2013
$35.97M(-54.4%)
$35.97M(-29.6%)
Sep 2013
-
$51.10M(-44.7%)
Jun 2013
-
$92.43M(-10.8%)
Mar 2013
-
$103.66M(+31.4%)
Dec 2012
$78.89M(+282.9%)
$78.89M(+42.9%)
Sep 2012
-
$55.20M(+222.2%)
Jun 2012
-
$17.13M(-42.7%)
Mar 2012
-
$29.92M(+45.3%)
Dec 2011
$20.60M(-55.1%)
$20.60M(-22.4%)
Sep 2011
-
$26.53M(-28.2%)
Jun 2011
-
$36.94M(-14.5%)
Mar 2011
-
$43.22M(-5.8%)
DateAnnualQuarterly
Dec 2010
$45.86M(+36.9%)
$45.86M(+4.8%)
Sep 2010
-
$43.77M(+17.4%)
Jun 2010
-
$37.27M(+41.5%)
Mar 2010
-
$26.34M(-21.4%)
Dec 2009
$33.51M(+359.8%)
$33.51M(-22.2%)
Sep 2009
-
$43.06M(+63.8%)
Jun 2009
-
$26.29M(+126.3%)
Mar 2009
-
$11.62M(+59.4%)
Dec 2008
$7.29M(-25.3%)
$7.29M(-31.7%)
Sep 2008
-
$10.67M(+20.8%)
Jun 2008
-
$8.83M(-27.3%)
Mar 2008
-
$12.14M(+24.5%)
Dec 2007
$9.75M(+209.5%)
$9.75M(+2.1%)
Sep 2007
-
$9.55M(+95.4%)
Jun 2007
-
$4.89M(+12.4%)
Mar 2007
-
$4.35M(+38.0%)
Dec 2006
$3.15M(+14.7%)
$3.15M(+44.3%)
Sep 2006
-
$2.18M(-3.6%)
Jun 2006
-
$2.26M(+2.5%)
Mar 2006
-
$2.21M(-19.6%)
Dec 2005
$2.75M(+22.2%)
$2.75M(+8.9%)
Sep 2005
-
$2.52M(+30.9%)
Jun 2005
-
$1.93M(-15.4%)
Mar 2005
-
$2.28M(+1.3%)
Dec 2004
$2.25M(-40.0%)
$2.25M(+66.7%)
Sep 2004
-
$1.35M(-37.7%)
Jun 2004
-
$2.17M(-21.2%)
Mar 2004
-
$2.75M(-26.7%)
Dec 2003
$3.75M(-26.8%)
$3.75M(+62.5%)
Sep 2003
-
$2.31M(+78.1%)
Jun 2003
-
$1.30M(-20.0%)
Mar 2003
-
$1.62M(-68.4%)
Dec 2002
$5.12M(+56.1%)
$5.12M(+4.2%)
Sep 2002
-
$4.92M(+24.3%)
Jun 2002
-
$3.96M(-16.2%)
Mar 2002
-
$4.72M(+43.9%)
Dec 2001
$3.28M(+90.5%)
$3.28M(+107.5%)
Sep 2001
-
$1.58M(-2.0%)
Jun 2001
-
$1.61M(-0.2%)
Mar 2001
-
$1.62M(-6.1%)
Dec 2000
$1.72M(+72.3%)
$1.72M(+30.9%)
Sep 2000
-
$1.32M(+19.2%)
Jun 2000
-
$1.10M(+44.0%)
Mar 2000
-
$767.00K(-23.3%)
Dec 1999
$1.00M(-16.7%)
$1.00M(+25.0%)
Sep 1999
-
$800.00K(+100.0%)
Jun 1999
-
$400.00K(-42.9%)
Mar 1999
-
$700.00K(-41.7%)
Dec 1998
$1.20M(+140.0%)
$1.20M(0.0%)
Sep 1998
-
$1.20M(+200.0%)
Jun 1998
-
$400.00K(-20.0%)
Mar 1998
-
$500.00K(0.0%)
Dec 1997
$500.00K(+66.7%)
$500.00K(-37.5%)
Sep 1997
-
$800.00K(-11.1%)
Jun 1997
-
$900.00K(+125.0%)
Mar 1997
-
$400.00K
Dec 1996
$300.00K
-

FAQ

  • What is Sarepta Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual current liabilities year-on-year change?
  • What is Sarepta Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly current liabilities year-on-year change?

What is Sarepta Therapeutics annual total current liabilities?

The current annual current liabilities of SRPT is $731.68M

What is the all time high annual current liabilities for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual total current liabilities is $731.68M

What is Sarepta Therapeutics annual current liabilities year-on-year change?

Over the past year, SRPT annual total current liabilities has changed by +$78.03M (+11.94%)

What is Sarepta Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of SRPT is $605.59M

What is the all time high quarterly current liabilities for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly total current liabilities is $731.68M

What is Sarepta Therapeutics quarterly current liabilities year-on-year change?

Over the past year, SRPT quarterly total current liabilities has changed by -$3.12M (-0.51%)
On this page